Squarepoint Ops LLC Atai Life Sciences N.V. Transaction History

Squarepoint Ops LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.27 - $2.6 $14,363 - $29,406	11,310 Added 90.79%	23,768 $31,000
Q1 2024 May 15, 2024	BUY	$1.5 - $2.19 $616 - $900	411 Added 3.41%	12,458 $24,000
Q4 2023 Feb 14, 2024	BUY	$1.04 - $1.55 $12,528 - $18,672	12,047 New	12,047 $16,000
Q2 2022 Aug 15, 2022	BUY	$3.03 - $5.32 $47,304 - $83,055	15,612 Added 58.18%	42,447 $155,000
Q1 2022 May 16, 2022	BUY	$4.66 - $7.66 $125,051 - $205,556	26,835 New	26,835 $137,000
Q4 2021 Feb 14, 2022	SELL	$6.82 - $17.8 $69,400 - $181,132	-10,176 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$13.62 - $19.48 $227,889 - $325,939	-16,732 Reduced 62.18%	10,176 $151,000
Q2 2021 Aug 16, 2021	BUY	$16.94 - $19.89 $455,821 - $535,200	26,908 New	26,908 $498,000

12.4M

77.8K

50.3K

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $197M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.